Navigation Links
David Anderson to discuss what model organisms can teach us about emotion
Date:2/20/2010

Scientists know little about how the brain creates and controls emotions an uncertainty that presents a major obstacle in the effort to develop treatments for emotional disorders. "The study of the brain science of emotion is in its infancy," says Howard Hughes Medical Institute (HHMI) investigator David Anderson, "yet emotional and psychiatric disorders continue to take an enormous toll on human society."

On February 20, 2010, at the American Association for the Advancement of Science's Annual Meeting in San Diego, Anderson, a neuroscientist at the California Institute of Technology, will discuss how studies of model organisms such as mice and fruit flies can improve scientists' understanding of the neural basis of emotion. That understanding, he says, is essential for developing more specific therapies for emotion disorders such as depression, anxiety, or attention deficit hyperactivity disorder (ADHD).

Anderson explains that while functional magnetic imaging (fMRI) studies of the human brain have linked neural activity in specific regions of the brain to particular emotional responses, there are limits to what can be learned from these types of studies. "We cannot tell which of these hotspots represents the actual cause of an emotional response, and which of them represents a reaction to the response," he says.

To makes that distinction, scientists must alter the activity of brain circuits in a targeted way, and then determine the consequences of the changes on emotional behavior. Such experiments are not possible on human subjects, and so scientists turn to model organisms. Anderson, whose own studies at Caltech and HHMI's Janelia Farm Research Campus explore the link between neural circuitry and emotional behaviors such as fear and aggression in both mice and fruit flies, will discuss the power and limitations of these types of experiments.

"We are in the midst of a revolution in the development of new technologies for experimentally manipulating brain circuitry," he says. Molecular and genetic tools that allow scientists to control when specific neurons are turned on in model organisms is already beginning to transform scientists' understanding of many aspects of brain function, including sensation, perception, cognition, and motor control. Anderson's presentation will address how to best apply these tools to the study of emotion.

"We need to know which animals are most suitable for studying this complex subject," he says. The laboratory mouse is amenable to powerful genetics techniques and it has a brain structure that is fundamentally similar to that of humans. But, he says, mouse research is slow, costly, technically difficult, and presents ethical challenges. Invertebrate model organisms, like the fruit fly Drosophila melanogaster, have simpler brains, more powerful genetic tools, and allow for faster, less expensive studies. "But can one study emotional behavior in a fly?" Anderson asks.


'/>"/>

Contact: Jennifer Michalowski
michalow@hhmi.org
301-215-8576
Howard Hughes Medical Institute
Source:Eurekalert

Related medicine news :

1. WorldHeart Appoints David Pellone Chief Financial Officer
2. Statement of Eli Lilly and Company on Dr. David Egilman Settlement:
3. David Ward Joins OrthoSynetics(TM) as Western Region Sales Manager
4. The Law Offices of John David Hart: Texas Man Sues Medtronic in Body-Snatching Case
5. Mylan Announces Appointment of David A. Lillback as Senior Vice President and Global Head of Human Resources
6. St. Davids Medical Center Implements New Robotic Technology to Treat Common Heart Rhythm Disorders
7. David Grimes, FHI physician, inducted into Institute of Medicine
8. David Kahal Joins AXA Equitable as National Sales Manager
9. Leading Authority on Health Benefits, David Hom, Joins Board of Directors of Healthcare Technology Innovator, NavigatorMD, Inc.
10. Tree named in honor of Virginia Tech chemist David G.I. Kingston
11. David Luci Joins MacroChem as General Counsel and Vice President Corporate Development
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/26/2017)... ... February 26, 2017 , ... IndustryArchive.Org . is announcing a ... Marketing. B2B Sellers will now only pay for B.A.N.T. quality sales leads based on ... IndustryArchive.Org, said, “Given the new reality that B2B buyers are controlling the sales process ...
(Date:2/26/2017)... , ... February 26, 2017 , ... ODH, Inc.™ ... Summit, February 27-28 at the Sheraton Pentagon City Hotel in Arlington, VA. ODH’s director ... to use behavioral health analytics to improve Medicaid population health management. , ODH will ...
(Date:2/26/2017)... ... February 26, 2017 , ... Occupational pesticide exposure ... a specific LRRK2 mutation, according to a study released today at the 1st ... of a link between pesticides and incidence of sporadic PD through occupational exposure. ...
(Date:2/24/2017)... ... 24, 2017 , ... HealthPostures, expert standing desk solution designer, ... built into the home office sit stand solution are bold colors, a new ... the benefits embedded in the TaskMate Go are available 24/7 through HealthPostures' online ...
(Date:2/24/2017)... ... 24, 2017 , ... Only two months after the official release of The ... Cannes (France), XO Private has initiated a second print-run of its lavish luxury travel ... metre across when open, weighs in at more than six kilos, retails at EUR ...
Breaking Medicine News(10 mins):
(Date:2/27/2017)... Feb. 27, 2017  A landmark study ... , MBBS, PhD, FRACS, of  Sydney Heart and ... Sydney will be published in the February 28, ... American College of Cardiology . According to the study, which ... bypass surgery technique (anOPCABG) reduced postoperative stroke ...
(Date:2/27/2017)...  International Biophysics Corporation, a global medical device manufacturer based ... 34% revenue growth in 2016 when compared to the previous ... growth was fueled by its AffloVest® sales in ... of its global sales of surgical product lines. ... enter our 25 th year in delivering high-quality, innovative ...
(Date:2/27/2017)... ROCKVILLE, Md. , Feb. 27, 2017 /PRNewswire/ ... "RegeneRx"), a clinical-stage drug development company focused on ... its licensee for RGN-137, GtreeBNT Co., Ltd., received ... its Phase 3 clinical trial design for RGN-137 ... dermal wound healing gel that incorporates Thymosin beta ...
Breaking Medicine Technology: